Association between late age at infectious mononucleosis, Epstein-Barr virus antibodies, and ovarian cancer risk

Scandinavian Journal of Infectious Diseases

Volumn 35, Issue 10, 2003, Pages 728-735

  Littman, Alyson J ^a,b   Rossing, Mary Anne ^a,b   Madeleine, Margaret M ^b   Tang, Mei Tzu ^b   Yasui, Yutaka ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; VIRUS ANTIBODY; VIRUS CAPSID ANTIGEN;

ADULT; AGE; AGED; ANTIBODY TITER; ARTICLE; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; EPSTEIN BARR VIRUS; EXPOSURE; FEMALE; HUMAN; HYPOTHESIS; INFECTIOUS MONONUCLEOSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; OVARY CANCER; POPULATION RESEARCH; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; AGED; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; INFECTIOUS MONONUCLEOSIS; LOGISTIC MODELS; MIDDLE AGED; ODDS RATIO; OVARIAN NEOPLASMS; PILOT PROJECTS; RISK FACTORS;

EID: 0242320193     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540310016556     Document Type: Article

References (32)

1. Weiss NS, Cook LS, Farrow DC, Rosenblatt KA. Ovarian cancer. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention, 2nd ed. New York: Oxford University Press; 1996. p. 1040-57.
2. Yasui Y, Potter JD, Stanford JL, Rossing MA, Winget MD, Bronner M, Daling J. Breast cancer risk and 'delayed' primary Epstein-Barr virus infection. Cancer Epidemiol Biomarkers Prev 2001; 10: 9-16.
3. Richardson A. Is breast cancer caused by late exposure to a common virus? Med Hypotheses 1997; 48: 491-7.
4. Niederman JC, Evans AS. Epstein-Barr Virus. In: Evans AS, Kaslow RA, eds. Viral infections of Humans: Epidemiology and Control, 4th ed. New York: Plenum Publishing Corp; 1997. p. 253-83.
5. Katz BZ. Viral infections of the upper respiratory tract, infectious mononucleosis, and the chronic fatigue syndrome. In: Shulman ST, Phair JP, Peterson LR, Warren JR, eds. The Biological and Clinical Basis of Infectious Diseases, 5th ed. Philadelphia: WB Saunders Company; 1997. p. 102-6.
6. Henderson B, Pike M, Bernstein L, Ross R. Breast cancer. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention, 2nd ed. New York: Oxford University Press; 1996. p. 893-919.
7. Parkin D, Whelan S, Ferlay J, Raymond L, Young J. Cancer Incidence in Five Continents. Lyon: IARC; 1997.
8. Daly M, Obrams GI. Epidemiology and risk assessment for ovarian cancer. Semin Oncol 1998; 25: 255-64.
9. Runnebaum IB, Stickeler E. Epidemiological and molecular aspects of ovarian cancer risk. J Cancer Res Clin Oncol 2001; 127: 73-9.
10. Cook LS, Kamb ML, Weiss NS. Perineal powder exposure and the risk of ovarian cancer. Am J Epidemiol 1997; 145: 459-65.
11. Hartge P, Brinton LA, Rosenthal JF, Cahill JI, Hoover RN, Waksberg J. Random digit dialing in selecting a population-based control group. Am J Epidemiol 1984; 120: 825-33.
12. Breslow NE, Day NE, Davis W. The analysis of case-control studies. Lyon: International Agency for Research on Cancer; 1980.
13. SAS Institute I. SAS/STAT user's guide, version 6. 4th ed. Cary, NC: SAS Institute, Inc., 1990.
14. Risch HA, Marrett LD, Jain M, Howe GR. Differences in risk factors for epithelial ovarian cancer by histological type. Results of a case-control study. Am J Epidemiol 1996; 144: 363-72.
15. Henle G, Henle W. Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol 1966; 91: 1248-56.
16. Horwitz CA, Henle W, Henle G, Rudnick H, Latts E. Long-term serological follow-up of patients for Epstein-Barr virus after recovery from infectious mononucleosis. J Infect Dis 1985; 151: 1150-3.
17. Reedman BM, Klein G. Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer 1973; 11: 499-520.
18. Schooley R. Epstein-Barr Virus (Infectious Mononucleosis). In: Mandell GL, Douglas RG, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 5th ed. Philadelphia: Churchill Livingstone; 2000. p. 1599-608.
19. Wrensch M, Weinberg A, Wiencke J, Miike R, Barger G, Kelsey K. Prevalence of antibodies to four herpes viruses among adults with glioma and controls. Am J Epidemiol 2001; 154: 161-5.
20. Mueller NE, Evans AS, London WT. Viruses. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention, 2nd ed. New York: Oxford University Press; 1996. p. 504-11.
21. Storch GA. Infectious Mononucleosis. In: Storch GA, ed. Essentials of Diagnostic Virology. New York: Churchill Livingstone; 2000. p. 159-66.
22. Okano M, Thiele GM, Davis JR, Grierson HL, Purtilo DT. Epstein-Barr virus and human diseases: recent advances in diagnosis. Clin Microbiol Rev 1988; 1: 300-12.
23. Magrath I, Bhatia K. Breast cancer: a new Epstein-Barr virus-associated disease? J Natl Cancer Inst 1999; 91: 1349-50.
24. Murray PG, Lissauer D, Junying J, Davies G, Moore S, Bell A, et al. Reactivity with a monoclonal antibody to Epstein-Barr virus (EBV) nuclear antigen 1 defines a subset of aggressive breast cancers in the absence of the EBV genome. Cancer Res 2003; 63: 2338-43.
25. Labrecque LG, Barnes DM, Fentiman IS, Griffin BE. Epstein-Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res 1995; 55: 39-45.
26. Ziegler J. An unlikely link? Researchers probe viral role in breast cancer. J Natl Cancer Inst 1997; 89: 608-10.
27. Bonnet M, Guinebretiere JM, Kremmer E, Grunewald V, Benhamou E, Contesso G, Joab I. Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst 2001; 91: 1376-81.
28. Glaser SL, Ambinder RF, DiGiuseppe JA, Horn-Ross PL, Hsu JL. Absence of Epstein-Barr virus EBER-1 transcripts in an epidemiologically diverse group of breast cancers. Int J Cancer 1998; 75: 555-8.
29. Kijima Y, Hokita S, Takao S, Baba M, Natsugoe S, Yoshinaka H, et al. Epstein-Barr virus involvement is mainly restricted to lymphoepithelial type of gastric carcinoma among various epithelial neoplasms. J Med Virol 2001; 64: 513-8.
30. McCall SA, Lichy JH, Bijwaard KE, Aguilera NS, Chu WS, Taubenberger JK. Epstein-Barr virus detection in ductal carcinoma of the breast. J Natl Cancer Inst 2001; 93: 148-50.
31. Chu PG, Chang KL, Chen YY, Chen WG, Weiss LM. No significant association of Epstein-Barr virus infection with invasive breast carcinoma. Am J Pathol 2001; 159: 571-8.
32. Vineis P, Miligi L, Crosignani P, Fontana A, Masala G, Nanni O, et al. Delayed infection, family size and malignant lymphomas. J Epidemiol Community Health 2000; 54: 907-11.